Antithrombotic Questionnaire Tool for Evaluation of Combined Antithrombotic Therapy in Community Pharmacies.

Autor:	van Uden RCAE, Sulaiman B; From the Pharmacy Foundation of Haarlem Hospitals, Haarlem, the Netherlands., Pols PAM; Community Pharmacy Heemsteedse pharmacy, Heemstede, the Netherlands., Meijer K; Department of Haematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van den Bemt PMLA; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Becker ML
Jazyk:	angličtina
Zdroj:	Journal of patient safety [J Patient Saf] 2024 Sep 01; Vol. 20 (6), pp. 404-409. Date of Electronic Publication: 2024 Jun 26.
DOI:	10.1097/PTS.0000000000001246
Abstrakt:	Objective: The objective of this paper is to assess the diagnostic value of an antithrombotic questionnaire tool compared with the hospital's medical record information tool. The hypothesis of this study was that the antithrombotic questionnaire tool could identify patients with potentially incorrect antithrombotic therapy. Methods: This cross-sectional study was conducted in eight community pharmacies in the Netherlands. A standardized questionnaire was developed as antithrombotic questionnaire tool. The pharmacist assessed whether the antithrombotic therapy was correct or potentially incorrect based on answers given by patients and based on the medical record. The primary outcome of the study was the sensitivity and specificity of the antithrombotic questionnaire tool to identify patients with potentially incorrect antithrombotic therapy. Results: For 95 patients, the pharmacist assessed that in 81 (85%) the antithrombotic therapy was correct and in 14 (15%) potentially incorrect. Based on the medical record, 86 patients (91%) were assessed as correct and 9 (9%) as potentially incorrect. The sensitivity of the tool was 100% and the specificity 94%. Conclusions: This study demonstrated that the antithrombotic questionnaire tool is a suitable tool to assess whether the patient's antithrombotic therapy is potentially incorrect. It can be applied to identify patients with potentially incorrect antithrombotic therapy. (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu